- In SCLC, DDR Inhibitors May Boost Immunotherapy Efficacy, Study Says – Immuno-Oncology News
- Better Muscle Mass Linked to Improved Immunotherapy Response – Asbestos.com
- Harnessing T-cell ‘stemness’ could enhance cancer immunotherapy – Science Daily
- Harnessing T-cell “stemness” could enhance cancer immunotherapy – National Institutes of Health
